GENENTECH, INC for GENENTECH INC

Medical/Disease Research/Clinical Labs MED

S. 2852 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 Issues related to public health protection including influenza development and preparedness Issues related to Right to Try Issues related to antimicrobial and antiviral research and product development

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); White House Office; Executive Office of the President (EOP); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2852 (115th)

Financial Institutions/Investments/Securities FIN

Foreign Investment Risk Review Modernization Act (FIRRMA) H.R. 5841/S. 2098 , legislation that would reform the Committee on Foreign Investment in the United States (CFIUS)

Contacted: Health & Human Services, Dept of (HHS); White House Office; SENATE; Executive Office of the President (EOP); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2098 (115th), H.R. 5841 (115th)

Taxation/Internal Revenue Code TAX

H.R.1, Tax Reform Act of 2017 (Public Law No. 115-97) Issues related to the tax reform bill and implementation

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); White House Office; SENATE

Bills named: H.R. 1 (115th)

Copyright/Patent/Trademark CPT

Intellectual property and process patent issues Patent litigation reform

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Office of Management & Budget (OMB); White House Office

Foreign Relations FOR

Issues related to Foreign Agents Registration Act (FARA), including Disclosing Foreign Influence Act -H.R. 4170/S. 2039

Contacted: Office of Management & Budget (OMB); White House Office; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); SENATE

Bills named: H.R. 4170 (115th), S. 2039 (115th)

Medicare/Medicaid MMM

H.R. 4710 - 340B Protecting Access for the Underserved and Safety-Net Entities Act (340B PAUSE Act) S. 2312 - The Helping Ensure Low-income Patients have Access to Care and Treatment Act S. 2453 - Ensuring the Value of the 340B Program Act of 2018 Part D Medicare Program (including Coverage Gap and other offsets in H.R.1892/P.L.115-123, Bipartisan Budget Act of 2018). HR 4392 - reversing the HOPPS rule reimbursement cut to 340B hospitals HR 5598 - 340B Optimization Act HR 2889 - Closing Loopholes for Orphan Drugs Act HR 6071 - SERV Communities Act HR 6240 - Drug Discount Accountability Act (user fees) Issues related to Medicare and Medicaid coverage and reimbursement Issues related to the 340B Drug Discount Program Issues related to drug pricing Medicare reimbursement for biosimilars MACRA treatment and reimbursement of Part B drugs Medicare payments for inpatient antimicrobials Issues related to Right to Try Issues related to drug importation Issues related to Part D Medicare Program including coverage gap and other offsets

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; White House Office

Bills named: H.R. 6240 (115th), H.R. 2889 (115th), S. 2453 (115th), S. 2312 (115th), H.R. 4710 (115th), H.R. 5598 (115th), H.R. 6071 (115th), H.R. 4392 (115th), H.R. 1892 (115th)

Trade (domestic/foreign) TRD

Issues relating to trade policy and negotiations impacting the biopharmaceutical industry

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; White House Office; Office of Management & Budget (OMB)

Health Issues HCR

H.R. 4710 - 340B Protecting Access for the Underserved and Safety-Net Entities (PAUSE) Act S. 2312 - The Helping Ensure Low-income Patients have Access to Care and Treatment Act S. 2453 - Ensuring the Value of the 340B Program Act of 2018 HR 4392 - Reversing the HOPPS rule reimbursement cut to 340B hospitals HR 5598 - 340B Optimization Act HR 2889 - Closing Loopholes for Orphan Drugs Act HR 6240 - Drug Discount Accountability Act (user fees) H.R.6071 - SERV Communities Act of 2018 S.204/H.R.878, Trickett-Wendler Right to Try Act of 2017 P.L.109-417, Pandemic and All-Hazards Preparedness Act (PAHPA) S.2852 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.6294 - Re-Valuing Anti-Microbial Products (REVAMP) Act of 2018 S.974 - CREATES Act of 2017 Issues related to the 340B Drug Discount Program Issues relating to drug pricing Development of policies to advance antimicrobial research, antiviral research, and novel product development environment, including advancing new market incentives. Issues and policies relating to the Food and Drug Administration including biopharmaceutical development, drug safety and counterfeiting, and biosimilars. General education about policies impacting pharmaceutical development, approval, reimbursement, and pricing. Issues related to healthcare legislation Issues related to public health protection including influenza development and preparedness

Contacted: SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; White House Office

Bills named: H.R. 4710 (115th), S. 2852 (115th), H.R. 6071 (115th), H.R. 878 (115th), H.R. 2889 (115th), H.R. 6240 (115th), H.R. 6294 (115th), S. 204 (115th), S. 974 (115th), H.R. 4392 (115th), H.R. 5598 (115th), S. 2312 (115th), S. 2453 (115th)

Budget/Appropriations BUD

H.R. 3358/S 1771 Departments of Labor, Health, and Human Services, and Education, and Related Agencies Appropriations Act, 2018 H.R.3268/S.1603, Agriculture, Rural Development, Food, and Drug Administration, and Related Agencies Appropriations Act, 2018 H.R.1370, Further Additional Continuing Appropriations Act, 2018 H.R.1892, Bipartisan Budget Act of 2018 H.R.1625, Consolidated Appropriations Act, 2018 Issues related to FDA and HHS program funding for the FY18 Labor, HHS, Education and Related Agencies, and FY18 Agriculture, Rural Developments, Food, and Drug Administrations, and Related Agencies Appropriation bills Issues related to FDA and HHS program funding for the FY19 Labor, HHS, Education and Related Agencies, and FY19 Agriculture, Rural Developments, Food, and Drug Administrations, and Related Agencies Appropriation bills

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB)

Bills named: H.R. 1370 (115th), H.R. 3358 (115th), H.R. 1892 (115th), H.R. 1625 (115th), H.R. 3268 (115th), S. 1603 (115th)

Pharmacy PHA

Drug Pricing Issues HR 4710, 340B Pause Act and other issues relating to the 340B Drug Discount Program

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); White House Office; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB)

Bills named: H.R. 4710 (115th)